49Z-27621-60942
3 vaccinations
2 coded responses
38 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 180 / PA
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-07
Registered in v-safe
-
2021-01-07
Dose 1 — Moderna
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-13
- 2021-01-16
- 2021-01-21
- 2021-01-28
-
2021-02-04
Dose 2 — Moderna
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-18
- 2021-02-27
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-08-05
-
2021-10-25
Dose 3 — Moderna
- 2021-10-25
-
2021-10-26
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
-
2021-10-27
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling, Itching · NoneAdult check-in
- 2021-10-28
- 2021-10-29
- 2021-10-30
- 2021-10-31
- 2021-11-01
- 2021-11-08
- 2021-11-15
- 2021-11-22
- 2021-11-29
- 2021-12-06
-
2022-01-24
Survey response — 3 months, dose 3MedDRA: Office visit, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Pregnancy · Healthcare visit (other): ObMedDRA releases: 2024-11 · check-in free text available
-
2022-01-24
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2022-01-26
- 2022-04-25
-
2022-10-25
Survey response — 12 months, dose 3MedDRA: Caesarean section, Pre-eclampsia — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, HospitalizationFree text: C-section- preeclampsiaMedDRA releases: 2024-11 · check-in free text available
-
2022-10-25
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Hospitalization · 1 call case(s)
-
2022-10-26
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-10-26
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Moderna | |
| 2 | 2021-02-04 | Moderna | |
| 3 | 2021-10-25 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-24 | Successful 2022-10-26 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-10-25 | Successful 2022-10-26 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 11 — 3 months, dose 3
Release 12 — 12 months, dose 3
Symptoms: C-section- preeclampsia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Caesarean section | · | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release